ArticleFrontiers in medicine2025
Proposing preoperative neutrophil percentage-to-albumin ratio as an effective prognostic factor for postoperative prognosis of distal cholangiocarcinoma: a retrospective cohort study.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The neutrophil percentage-to-albumin ratio (NPAR) is a novel inflammatory-nutritional biomarker that has prognostic value in various cancers. This study aimed to evaluate the predictive value of preoperative NPAR for postoperative prognosis in patients with distal cholangiocarcinoma (dCCA). Methods: We retrospectively analyzed dCCA patients who underwent radical surgery between January 2011 and December 2023. Independent risk factors were identified using univariate and multivariate analysis. The prognostic performance of NPAR was assessed using receiver operating characteristic (ROC) curve analysis, and the optimal cutoff value was determined. Survival outcomes were compared using the log-rank test, and propensity score matching (PSM) was applied to adjust for confounders. Predictive models were developed using multiple machine-learning algorithms. Results: Among 192 included patients, NPAR demonstrated an area under the ROC curve of 0.702 inpredicting postoperative survival, with an optimal cutoff value of 1.735. Multivariate analysis confirmed that elevated preoperative NPAR was an independent risk factor for both disease-free survival (DFS) and overall survival (OS). Patients with NPAR > 1.735 had significantly worse postoperative outcomes. Subgroup analysis indicated that NPAR had stronger predictive value in patients with tumor invasion depth > 12 mm, but without portal vein invasion or lymph node metastasis. Machine-learning models incorporating NPAR improved the prediction of postoperative prognosis in dCCA. Conclusion: Elevated preoperative NPAR (>1.735) is an independent risk factor for postoperative DFS and OS in dCCA patients and may serve as a potential prognostic index.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.